GLIMECHECK MV 3.3

GLIMECHECK MV 3.3 Tablet is a triple combination medicine used to manage type 2 diabetes mellitus in adults. It combines Glimepiride, Metformin, and Voglibose, which work together to help control high blood sugar levels more effectively when diet, exercise, and single or dual therapy do not provide adequate control.

• Glimepiride (3mg): Stimulates the pancreas to release more insulin.

• Metformin (500mg or 1000mg – confirm your exact strength): Reduces sugar production in the liver and improves insulin sensitivity.

• Voglibose (0.3mg): Delays glucose absorption in the intestine, helping to control post-meal sugar spikes.

✅ Key Benefits

• Effective triple-action therapy for type 2 diabetes

• Better control of fasting and post-meal blood sugar levels

• Helps reduce the risk of long-term diabetes complications

• Works when single or dual therapy is insufficient